Membrane restructuring via ceramide results in enhanced solute efflux.
The capacity of ceramides to modify the permeability barrier of cell membranes has been explored. Membrane efflux induced either by in situ generated ceramides (through enzymatic cleavage of sphingomyelin) or by addition of ceramides to preformed membranes has been studied. Large unilamellar vesicles composed of different phospholipids and cholesterol, and containing entrapped fluorescent molecules, have been used as a system to assay ceramide-dependent efflux. Small proportions of ceramide (10 mol % of total lipid) that may exist under physiological conditions of ceramide-dependent signaling have been used in most experiments. When long chain (egg-derived) ceramides are used, both externally added or enzymatically produced ceramides induce release of vesicle contents. However, the same proportion of ceramides generated by sphingomyelinase induce faster and more extensive efflux than when added in organic solution to the preformed vesicles. Under our conditions 10 mol % of N-acetylsphingosine (C(2)-ceramide) did not induce any efflux. On the other hand, sphingomyelinase treatment of bilayers containing 50 mol % sphingomyelin gave rise to release of fluorescein-derivatised dextrans of molecular mass approximately 20 kDa, i.e. larger than cytochrome c. These results have been discussed in the light of our own previous data (Ruiz-Argüello, M. B., Basañez, G., Goñi, F. M., and Alonso, A. (1996) J. Biol. Chem. 271, 26616-26621) and of the observations by Siskind and Colombini (Siskind, L. J., and Colombini, M. (2000) J. Biol. Chem. 275, 38640-38644). Our spectroscopic observations appear to be in good agreement with the electrophysiological studies of the latter authors. Furthermore, some experiments in this paper have been designed to explore the mechanism of ceramide-induced efflux. Two properties of ceramide, namely its capacity to induce negative monolayer curvature and its tendency to segregate into ceramide-rich domains, appear to be important in the membrane restructuring process.
Montes
L Ruth
LR
Unidad de Biofisica (Centro Mixto Consejo Superior de Investigaciones Cientificas/Universidad del Pais Vasco/Euskal Herriko Unibertsitatea) Bilbao, Spain.
Ruiz-Argüello
M Begoña
MB
Goñi
Félix M
FM
Alonso
Alicia
A
D001409:Bacillus cereus / Q000201:enzymology; D001669:Biochemical Phenomena; D001671:Biochemistry; D002462:Cell Membrane / Q000378:metabolism*; D002518:Ceramides / Q000494:pharmacology*; D002784:Cholesterol / Q000378:metabolism; D008051:Lipid Bilayers / Q000737:chemistry; D008055:Lipids / Q000737:chemistry; D017434:Protein Structure, Tertiary; D015398:Signal Transduction; D013053:Spectrophotometry; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D013997:Time Factors
D002518:Ceramides; D008051:Lipid Bilayers; D008055:Lipids; C064769:N-acetylsphingosine; D002784:Cholesterol; D013110:Sphingosine